 Krishna Mallela
Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystrophin | 7 | 2024 | 35 | 3.410 |
Why?
| | Utrophin | 6 | 2017 | 7 | 2.770 |
Why?
| | Microfilament Proteins | 6 | 2017 | 133 | 2.580 |
Why?
| | Calcium-Binding Proteins | 6 | 2017 | 218 | 2.230 |
Why?
| | Protein Aggregates | 6 | 2025 | 72 | 2.150 |
Why?
| | Protein Binding | 18 | 2025 | 2224 | 2.090 |
Why?
| | Protein Unfolding | 6 | 2018 | 31 | 1.870 |
Why?
| | Actins | 6 | 2017 | 416 | 1.760 |
Why?
| | Interferon-alpha | 4 | 2018 | 198 | 1.750 |
Why?
| | Antibodies, Monoclonal | 4 | 2025 | 1430 | 1.610 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 109 | 1.550 |
Why?
| | Polysorbates | 2 | 2025 | 41 | 1.480 |
Why?
| | Protein Folding | 15 | 2010 | 280 | 1.420 |
Why?
| | Thermodynamics | 12 | 2024 | 407 | 1.400 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 286 | 1.390 |
Why?
| | Protein Stability | 9 | 2025 | 176 | 1.180 |
Why?
| | Preservatives, Pharmaceutical | 3 | 2014 | 26 | 1.170 |
Why?
| | Cytochromes c | 6 | 2011 | 60 | 1.160 |
Why?
| | Calorimetry | 2 | 2025 | 70 | 1.090 |
Why?
| | Dependovirus | 2 | 2025 | 68 | 1.070 |
Why?
| | Genetic Vectors | 2 | 2025 | 319 | 1.010 |
Why?
| | Poloxamer | 1 | 2025 | 13 | 0.940 |
Why?
| | Silicone Oils | 1 | 2025 | 28 | 0.930 |
Why?
| | Dystrophin-Associated Proteins | 1 | 2024 | 6 | 0.920 |
Why?
| | Benzyl Alcohol | 3 | 2014 | 12 | 0.900 |
Why?
| | Immunoglobulin G | 3 | 2025 | 893 | 0.890 |
Why?
| | Protein Conformation | 8 | 2018 | 934 | 0.880 |
Why?
| | Models, Molecular | 15 | 2018 | 1570 | 0.880 |
Why?
| | Surface Plasmon Resonance | 1 | 2024 | 87 | 0.840 |
Why?
| | Protein Structure, Secondary | 14 | 2019 | 374 | 0.830 |
Why?
| | Protein Isoforms | 1 | 2024 | 404 | 0.810 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2022 | 16 | 0.800 |
Why?
| | Protein Structure, Tertiary | 10 | 2021 | 861 | 0.790 |
Why?
| | Mutation, Missense | 3 | 2014 | 341 | 0.770 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2025 | 804 | 0.760 |
Why?
| | Methionine | 2 | 2019 | 160 | 0.740 |
Why?
| | Anti-Infective Agents | 2 | 2014 | 255 | 0.680 |
Why?
| | Amyloid beta-Peptides | 1 | 2022 | 220 | 0.660 |
Why?
| | Asparagine | 1 | 2019 | 31 | 0.640 |
Why?
| | Drug Compounding | 2 | 2023 | 101 | 0.610 |
Why?
| | Protein Subunits | 2 | 2012 | 239 | 0.580 |
Why?
| | Horses | 9 | 2012 | 111 | 0.580 |
Why?
| | Excipients | 1 | 2018 | 55 | 0.580 |
Why?
| | Oxidants | 1 | 2018 | 111 | 0.570 |
Why?
| | Protein Domains | 3 | 2024 | 289 | 0.550 |
Why?
| | Lymphokines | 1 | 2017 | 131 | 0.540 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2017 | 59 | 0.540 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2017 | 41 | 0.540 |
Why?
| | Ketones | 1 | 2017 | 49 | 0.540 |
Why?
| | Aldehydes | 1 | 2017 | 145 | 0.510 |
Why?
| | Drug Stability | 3 | 2025 | 167 | 0.510 |
Why?
| | Recombinant Proteins | 5 | 2021 | 1353 | 0.500 |
Why?
| | Protein Denaturation | 5 | 2011 | 74 | 0.490 |
Why?
| | Molecular Chaperones | 1 | 2017 | 195 | 0.480 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1060 | 0.480 |
Why?
| | Circular Dichroism | 4 | 2025 | 149 | 0.470 |
Why?
| | Light | 1 | 2018 | 381 | 0.470 |
Why?
| | Cresols | 2 | 2014 | 4 | 0.470 |
Why?
| | Kinetics | 11 | 2024 | 1670 | 0.460 |
Why?
| | Adsorption | 2 | 2025 | 149 | 0.460 |
Why?
| | Amino Acid Sequence | 6 | 2018 | 2139 | 0.440 |
Why?
| | Binding Sites | 4 | 2023 | 1303 | 0.430 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 307 | 0.420 |
Why?
| | Antiviral Agents | 1 | 2018 | 744 | 0.390 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2025 | 187 | 0.350 |
Why?
| | Hydrogen-Ion Concentration | 8 | 2025 | 560 | 0.340 |
Why?
| | Biophysical Phenomena | 4 | 2015 | 64 | 0.340 |
Why?
| | Cytochrome c Group | 5 | 2004 | 43 | 0.340 |
Why?
| | Muscular Dystrophies | 1 | 2010 | 36 | 0.330 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2900 | 0.320 |
Why?
| | Mutation | 5 | 2022 | 3958 | 0.320 |
Why?
| | Proteins | 5 | 2024 | 1009 | 0.290 |
Why?
| | Surface-Active Agents | 2 | 2020 | 91 | 0.290 |
Why?
| | Hydrogen | 6 | 2004 | 70 | 0.270 |
Why?
| | Humans | 19 | 2025 | 137585 | 0.270 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 4 | 2018 | 340 | 0.260 |
Why?
| | Cell Line, Tumor | 3 | 2018 | 3412 | 0.250 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2017 | 150 | 0.240 |
Why?
| | Single-Domain Antibodies | 1 | 2025 | 15 | 0.240 |
Why?
| | Serogroup | 1 | 2025 | 44 | 0.230 |
Why?
| | Emulsions | 1 | 2025 | 53 | 0.230 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2024 | 2189 | 0.230 |
Why?
| | Osmolar Concentration | 1 | 2025 | 171 | 0.230 |
Why?
| | Filtration | 1 | 2025 | 72 | 0.230 |
Why?
| | beta-Arrestins | 1 | 2024 | 15 | 0.230 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2015 | 385 | 0.220 |
Why?
| | Molecular Docking Simulation | 1 | 2024 | 114 | 0.220 |
Why?
| | Entropy | 1 | 2024 | 41 | 0.220 |
Why?
| | Receptors, Opioid, mu | 1 | 2024 | 74 | 0.220 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2024 | 89 | 0.210 |
Why?
| | Amino Acids | 2 | 2019 | 497 | 0.210 |
Why?
| | Protein Interaction Mapping | 1 | 2024 | 109 | 0.210 |
Why?
| | Receptors, Virus | 1 | 2023 | 83 | 0.210 |
Why?
| | Morphine | 1 | 2024 | 158 | 0.200 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2023 | 105 | 0.200 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2022 | 32 | 0.200 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2022 | 18 | 0.200 |
Why?
| | HEK293 Cells | 2 | 2024 | 730 | 0.200 |
Why?
| | Mutant Proteins | 2 | 2014 | 103 | 0.190 |
Why?
| | Benzoquinones | 1 | 2022 | 48 | 0.190 |
Why?
| | NAD | 1 | 2022 | 77 | 0.190 |
Why?
| | Fluorescent Dyes | 4 | 2012 | 321 | 0.190 |
Why?
| | Deuterium Exchange Measurement | 3 | 2007 | 30 | 0.190 |
Why?
| | Immune Evasion | 1 | 2022 | 58 | 0.180 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 55 | 0.180 |
Why?
| | Transition Temperature | 1 | 2021 | 26 | 0.180 |
Why?
| | Saccharomyces cerevisiae | 1 | 2025 | 557 | 0.170 |
Why?
| | Cell Proliferation | 2 | 2018 | 2475 | 0.170 |
Why?
| | Protein Multimerization | 2 | 2012 | 192 | 0.170 |
Why?
| | Polyethylene Glycols | 1 | 2025 | 641 | 0.160 |
Why?
| | Animals | 12 | 2022 | 36940 | 0.160 |
Why?
| | Escherichia coli | 2 | 2014 | 815 | 0.150 |
Why?
| | tert-Butylhydroperoxide | 1 | 2018 | 10 | 0.150 |
Why?
| | Amidines | 1 | 2018 | 14 | 0.150 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2019 | 375 | 0.150 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2018 | 41 | 0.150 |
Why?
| | Nanoparticles | 2 | 2025 | 481 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2017 | 611 | 0.140 |
Why?
| | Protein Aggregation, Pathological | 1 | 2018 | 21 | 0.140 |
Why?
| | Temperature | 2 | 2012 | 679 | 0.140 |
Why?
| | Models, Biological | 4 | 2008 | 1783 | 0.140 |
Why?
| | Proteolysis | 1 | 2018 | 177 | 0.140 |
Why?
| | Receptors, Fc | 1 | 2018 | 53 | 0.140 |
Why?
| | Unfolded Protein Response | 1 | 2017 | 59 | 0.140 |
Why?
| | Hydrolysis | 1 | 2017 | 177 | 0.140 |
Why?
| | Molecular Weight | 1 | 2017 | 335 | 0.130 |
Why?
| | Solubility | 1 | 2017 | 245 | 0.130 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 328 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2018 | 203 | 0.130 |
Why?
| | Adenosine Triphosphatases | 1 | 2017 | 168 | 0.130 |
Why?
| | Structural Homology, Protein | 1 | 2015 | 27 | 0.120 |
Why?
| | Carbocyanines | 3 | 2001 | 33 | 0.120 |
Why?
| | Mass Spectrometry | 1 | 2018 | 739 | 0.110 |
Why?
| | Liposomes | 2 | 2025 | 223 | 0.110 |
Why?
| | Ethylene Glycols | 1 | 2014 | 16 | 0.110 |
Why?
| | Phenol | 1 | 2014 | 19 | 0.110 |
Why?
| | SUMO-1 Protein | 1 | 2014 | 21 | 0.110 |
Why?
| | Bacterial Load | 1 | 2014 | 68 | 0.110 |
Why?
| | Chromatography, Gel | 1 | 2014 | 127 | 0.110 |
Why?
| | Cysteine Endopeptidases | 1 | 2014 | 73 | 0.110 |
Why?
| | Biochemistry | 2 | 2008 | 38 | 0.110 |
Why?
| | Area Under Curve | 1 | 2014 | 314 | 0.100 |
Why?
| | Cloning, Molecular | 1 | 2014 | 534 | 0.100 |
Why?
| | Pyrenes | 1 | 2012 | 6 | 0.100 |
Why?
| | Crystallography, X-Ray | 1 | 2014 | 476 | 0.100 |
Why?
| | Solutions | 1 | 2012 | 168 | 0.100 |
Why?
| | In Vitro Techniques | 2 | 2010 | 1092 | 0.090 |
Why?
| | Caveolae | 1 | 2001 | 18 | 0.090 |
Why?
| | Cysteine | 1 | 2012 | 204 | 0.090 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 665 | 0.090 |
Why?
| | Cattle | 1 | 2014 | 984 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2012 | 343 | 0.090 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2014 | 385 | 0.090 |
Why?
| | Membrane Lipids | 1 | 2001 | 91 | 0.080 |
Why?
| | Solvents | 1 | 2010 | 109 | 0.080 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 156 | 0.080 |
Why?
| | Anesthetics, Local | 1 | 2010 | 80 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 2 | 2005 | 168 | 0.080 |
Why?
| | Multiprotein Complexes | 1 | 2010 | 163 | 0.080 |
Why?
| | Lipid Bilayers | 1 | 1999 | 98 | 0.080 |
Why?
| | Cell Line | 1 | 2014 | 2847 | 0.070 |
Why?
| | Micrococcal Nuclease | 1 | 2008 | 26 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3566 | 0.070 |
Why?
| | Phosphatidylcholines | 1 | 1997 | 147 | 0.070 |
Why?
| | Models, Chemical | 4 | 2008 | 263 | 0.060 |
Why?
| | Methyl Ethers | 1 | 2005 | 13 | 0.060 |
Why?
| | Receptors, GABA | 1 | 2005 | 14 | 0.060 |
Why?
| | Halothane | 1 | 2005 | 7 | 0.060 |
Why?
| | Anesthetics, Inhalation | 1 | 2005 | 35 | 0.060 |
Why?
| | Ferric Compounds | 1 | 2025 | 56 | 0.060 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 219 | 0.050 |
Why?
| | Flow Cytometry | 1 | 2025 | 1178 | 0.040 |
Why?
| | Gene Transfer Techniques | 1 | 2021 | 170 | 0.040 |
Why?
| | Fluorescence Polarization | 2 | 2001 | 37 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2021 | 297 | 0.040 |
Why?
| | Particle Size | 1 | 2020 | 394 | 0.040 |
Why?
| | Egg Proteins | 1 | 2007 | 17 | 0.030 |
Why?
| | Muramidase | 1 | 2007 | 78 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1000 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2005 | 225 | 0.030 |
Why?
| | Probability | 1 | 2005 | 304 | 0.030 |
Why?
| | Time Factors | 2 | 2004 | 6828 | 0.030 |
Why?
| | Biophysics | 1 | 2002 | 71 | 0.020 |
Why?
| | Tritium | 1 | 2001 | 76 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 2001 | 163 | 0.020 |
Why?
| | Rotation | 1 | 2001 | 117 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2001 | 148 | 0.020 |
Why?
| | History, 20th Century | 1 | 2001 | 325 | 0.020 |
Why?
| | Surface Properties | 1 | 2001 | 413 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1999 | 99 | 0.020 |
Why?
| | Sucrose | 1 | 1999 | 110 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2001 | 597 | 0.020 |
Why?
| | Guanidine | 1 | 2008 | 21 | 0.020 |
Why?
| | Molecular Structure | 1 | 1999 | 489 | 0.020 |
Why?
| | Enzyme Stability | 1 | 2007 | 70 | 0.020 |
Why?
| | Amides | 1 | 2007 | 93 | 0.020 |
Why?
| | Protons | 1 | 2006 | 89 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2008 | 578 | 0.010 |
Why?
| | Titrimetry | 1 | 2003 | 12 | 0.010 |
Why?
| | Spectrum Analysis | 1 | 2003 | 91 | 0.010 |
Why?
| | Proteomics | 1 | 2008 | 1111 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2008 | 3284 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2005 | 2607 | 0.010 |
Why?
|
|
Mallela's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|